{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:19Z","timestamp":1787032819829,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,16]]},"DOI":"10.7759\/cureus.15682","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T06:16:55Z","timestamp":1623824215000},"source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Hepatitis: Treatment Options and Management Review"],"prefix":"10.7759","author":[{"given":"Eyad","family":"Gadour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns MP","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010, 51:2193-213. 10.1002\/hep.23584","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson D","year":"2011","unstructured":"Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011, 60:1611-29. 10.1136\/gut.2010.235259","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1089-3261(02)00018-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"6","author":"Vergani D","year":"2002","unstructured":"Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002, 6:727-37. 10.1016\/s1089-3261(02)00018-1","journal-title":"Clin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.1.1.113","article-title":"Autoimmune hepatitis. Part A: pathogenesis","volume":"1","author":"Czaja AJ","year":"2007","unstructured":"Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol. 2007, 1:113-28. 10.1586\/17474124.1.1.113","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref5","article-title":"Diverse manifestations and evolving treatments of autoimmune hepatitis","volume":"51","author":"Czaja AJ","year":"2005","unstructured":"Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol Dietol. 2005, 51:313-33.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan J","year":"2002","unstructured":"Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol. 2002, 35:75-81. 10.1097\/00004836-200207000-00016","journal-title":"J Clin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld JJ","year":"2005","unstructured":"Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005, 42:53-62. 10.1002\/hep.20732","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler WR","year":"2004","unstructured":"Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004, 2:625-31. 10.1016\/s1542-3565(04)00246-0","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja AJ","year":"2002","unstructured":"Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002, 97:2051-7. 10.1111\/j.1572-0241.2002.05921.x","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi T","year":"2008","unstructured":"Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol. 2008, 48:140-7. 10.1016\/j.jhep.2007.08.013","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg KM","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998, 33:99-103. 10.1080\/00365529850166284","journal-title":"Scand J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner M","year":"2008","unstructured":"Werner M, Prytz H, Ohlsson B, et al.. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008, 43:1232-40. 10.1080\/00365520802130183","journal-title":"Scand J Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway RD","year":"1972","unstructured":"Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitni\u0107k GL, Elveback IR, Schoenfield LJ. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972, 63:820-8.","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","unstructured":"EASL Clinical Practice Guidelines. autoimmune hepatitis. J Hepatol. 2015, 63:971-1004. 10.1016\/j.jhep.2015.06.030","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez F","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31:929-38. 10.1016\/s0168-8278(99)80297-9","journal-title":"J Hepatol"},{"key":"ref16","article-title":"Autoimmune hepatitis","volume":"4","author":"Prieto Ortiz JE","year":"2012","unstructured":"Prieto Ortiz JE, Preciado J, Huertas Pacheco S. Autoimmune hepatitis. Rev Col Gastroenterol. 2012, 4:303-15.","journal-title":"Rev Col Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza AJ","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol. 2007, 102:1005-12. 10.1111\/j.1572-0241.2007.01153.x","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.011","article-title":"Autoimmune hepatitis in special patient populations","volume":"25","author":"Czaja AJ","year":"2011","unstructured":"Czaja AJ. Autoimmune hepatitis in special patient populations. Best Pract Res Clin Gastroenterol. 2011, 25:689-700. 10.1016\/j.bpg.2011.09.011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan MA","year":"2001","unstructured":"Heneghan MA, Portmann BC, Norris SM, et al.. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology. 2001, 34:464-70. 10.1053\/jhep.2001.26756","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","author":"Aguilera I","year":"2001","unstructured":"Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, Garc\u00eda-Lozano JR, N\u00fa\u00f1ez-Rold\u00e1n A. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol. 2001, 126:535-9. 10.1046\/j.1365-2249.2001.01682.x","journal-title":"Clin Exp Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(00)02826-8","article-title":"A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis","volume":"33","author":"Spada M","year":"2001","unstructured":"Spada M, Bertani A, Sonzogni A, et al.. A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. Transplant Proc. 2001, 33:1747-8. 10.1016\/s0041-1345(00)02826-8","journal-title":"Transplant Proc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression","volume":"97","author":"Ortiz V","year":"2002","unstructured":"Ortiz V, Berenguer M, Ray\u00f3n JM, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol. 2002, 97:2408-14. 10.1111\/j.1572-0241.2002.05995.x","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c912","article-title":"Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study","volume":"340","author":"Liu B","year":"2010","unstructured":"Liu B, Balkwill A, Reeves G, Beral V. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ. 2010, 340:c912. 10.1136\/bmj.c912","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","unstructured":"EASL clinical practice guidelines. management of chronic hepatitis B virus infection. J Hepatol. 2012, 57:167-85. 10.1016\/j.jhep.2012.02.010","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61265-autoimmune-hepatitis-treatment-options-and-management-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:35:16Z","timestamp":1707489316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61265-autoimmune-hepatitis-treatment-options-and-management-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.15682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,16]]}}}